Human medicines European public assessment report (EPAR): Scintimun, besilesomab, Date of authorisation: 11/01/2010, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Neofordex, dexamethasone, Date of authorisation: 16/03/2016, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Kineret, anakinra, Date of authorisation: 08/03/2002, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Orphacol, cholic acid, Date of authorisation: 12/09/2013, Revision: 19, Status: Authorised

Records of data processing activity regarding EMA Account Management System (public)

Sixteenth industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, from 2 July 2026, 12:30 (CEST) to 2 July 2026, 17:30 (CEST)

2025-2028 Work plan for the Patients’ and Consumers’ Working Party (PCWP) and the Healthcare Professionals’ Working Party (HCPWP)

Human medicines European public assessment report (EPAR): Efmody, hydrocortisone, Date of authorisation: 27/05/2021, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Avtozma, tocilizumab, Date of authorisation: 14/02/2025, Revision: 6, Status: Authorised

Agenda - Clinical trials information system information day webinar